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Abstract
Physical and chemical modifications of chitin and chitosan allow for obtaining 
new functional properties of the natural polymers. This is a particularly valuable 
feature for the design and manufacture of new materials for medical applications. 
Due to their wide and varied biological activity, chitin and chitosan materials are 
increasingly used as dressing materials with antibacterial and hemostatic proper-
ties and as materials accelerating the regeneration of damaged tissues because of 
stimulation of granulation tissue formation, re-epithelialization and reduction of the 
formation of scar tissue. In addition, chitosan derivatives have antifungal, antiviral, 
anticancer activity. The increasing use of chitin and chitosan also has a positive 
impact on the environment, as it is obtained as a result of chitin deacetylation, usu-
ally isolated from shellfish shells. The main source of chitin is waste coating of crus-
taceans. The annual natural reproducibility of chitin by biosynthesis is estimated 
at 2–3 billion tons. Our interest in the use of biodegradable biopolymers derived 
from chitin concerns the design, synthesis in laboratory scale, testing new material 
properties and the final implementation of new developments for industrial practice 
of new dressing materials useful in the treatment of bleeding wounds (haemostatic 
properties) as well as in the regeneration of wounds and ulcers of various etiolo-
gies. Examples of chitin-based dressing materials introduced by Tricomed SA are 
Medisorb R Ag, Medisorb R Membrane, Medisorb R Powder and Tromboguard®.
Keywords: chitin, chitosan, chemical modification, biological properties,  
dressing materials, manufacturing on an industrial scale
1. Introduction
Chitin and chitosan belong to the polymeric materials of natural origin from 
the polysaccharides group. The widely used polysaccharides of natural origin 
also include cellulose and derivatives of hyaluronic and alginic acid. Use for the 
production of medical devices (contact with the patient’s body), makes them meet 
several requirements: they should maintain their physicochemical properties after 
Chitin and Chitosan - Physicochemical Properties and Industrial Applications
2
treatment at elevated temperature during sterilization, after exposure to X-ray, 
detergents and aseptic. Polysaccharide biopolymers, like most polymeric materi-
als, degrade after some time of use, so it is also important that their decomposition 
products do not cause inflammation, allergic or immune reactions or any other 
interactions with patients’ bodies.
Chitin is a polysaccharide composed of N-acetylglucosamine residues linked by 
β-1,4-glycosidic bonds. Chitin is the main component of the fungal walls and the 
shells of arthropods (crustaceans, insects, and arachnids), but is also present in 
sponges, corals, and mollusks. However, for laboratory and industrial purposes, it 
is obtained mainly from marine invertebrates such as: crabs, shrimps, lobsters and 
krill. The properties of chitin depend on its origin. Chitin used in the production 
of medical devices must come from certified, controlled fisheries and must be 
properly purified. The methods of isolating chitin from natural sources are strictly 
dependent on the choice of the organism from which it is isolated. This polysaccha-
ride is similar in structure to cellulose. It differs in the presence of an acetyl amide 
group (-NHCOCH3) in place of one of the hydroxyl groups (Figure 1). The presence 
of this group means that there are much stronger intermolecular hydrogen bonds in 
chitin, which results in its greater mechanical strength compared to cellulose [1, 2].
Depending on the origin source, chitin can occur in three amorphous forms: α, 
β and γ [2, 3]. The most widespread is α chitin found in fungi, shells of crustaceans 
and krill, and the skeletons of insects. The β form, which can mainly be isolated 
from squids, is much less common. The differences in the crystal structure of both 
amorphous forms of chitin affect their processing capabilities. The ordered crystal 
structure of chitin limits its solubility in commonly used solvents, and thus, reduces 
its use in industry. α-Chitin is moderately soluble in aqueous thiourea solution, 
aqueous alkaline urea solution, 5% LiCl/DMAC, some ionic liquids, hexafluoroac-
etone, hexafluoro-2-propanol, methanesulfonic acid [4, 5]. The form of β-chitin, 
on the other hand, swells in water (forms a suspension) and is soluble in formic 
acid. Chitin has no cytotoxic effect in vitro, is physiologically inert, biodegradable, 
has antibacterial properties and is characterized by a high affinity to proteins. 
During its biodegradation in the wound environment, its oligomers and units are 
released. Most often, it is used in the form of gel, membranes, fibers, polymer films 
or is a component of polymer blends. Chitin activates macrophages, stimulates the 
proliferation of fibroblasts and influences vascularization [6–11].
Despite the very good biological properties of chitin, its practical use is mod-
erate, which is related to its low solubility causing difficulties in its processing. 
Therefore, chitin is used as a raw material to obtain new derivatives with better 
performance parameters. In terms of practical use, the most important chitin 
derivatives are its esters and chitosan, which is a product of chitin deacetylation, 
which can be classified into the group of amino-polysaccharides.
Figure 1. 
Structural resemblance of cellulose, chitin and chitosan.
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2. Chitin esters - materials with tailored functional properties
2.1 Chitin esters in dressing materials
The esterification of chitin hydroxyl groups allows to increase the utility poten-
tial of the polysaccharide by introducing various substituents, and thus, influencing 
the physical, chemical and biological properties of materials. The best known are 
chitin esters, in which the hydroxyl groups are esterified with one type of acylat-
ing reagent (presence of the same ester groups on both hydroxyl groups of chitin). 
Acetylated chitin derivatives (CH3CO- substituent) are prepared with acetic anhy-
dride in the presence of an acid catalyst. However, the physicochemical properties 
conditioning the processing of chitin acetate turned out to be unsatisfactory [12]. 
The use of a mixture of orthophosphoric acid and trifluoroacetic acid anhydride 
as a catalyst allowed to obtain a variety of chitin esters derived from: butyric acid, 
cyclopropanecarboxylic acid, cyclobutanecarboxylic acid, cyclopentanecarboxylic 
acid, cyclohexanecarboxylic acid and substituted benzoic acids. In the case of 
chitin butyrate, the process efficiency (DS (degree of substitution) included in the 
range 1.9–2.38) was dependent on the excess of butyric acid anhydride use [13–15]. 
Di-butyrylchitin (chitin di-butyrate, DBC) is an example of a chitin derivative 
soluble in typical organic solvents [16]. DBC is obtained by chitin esterification 
with butyric anhydride. Typically, it is a two-stage process. In the first step, chitin is 
purified from calcium salts with 2 M hydrochloric acid. The next stage is the process 
of proper esterification of purified chitin. The substrates of the reaction, apart from 
chitin, are butyric anhydride and the catalyst, which is most often chloric (VII) 
acid. The reaction is carried out in a heterogeneous system by adding powdered 
chitin in appropriate proportions to the reaction mixture consisting of butyric 
anhydride and chloric (VII) acid. The classical esterification process requires the 
use of substrates in a molar ratio of acid anhydride to N-acetylaminoglucose unit of 
10: 1. It is also crucial to carry out the reaction at a temperature of 20°C. Increasing 
the reaction temperature to 40°C causes a rapid lowering of the molecular weight 
of the modified polymer. The catalyst concentration has a direct influence on the 
efficiency of the esterification reaction. The yield of the reaction is the higher when 
more concentrated chloric (VII) acid is used. However, it should be remembered 
that the use of too much concentrated chloric (VII) acid results in the macromol-
ecule degradation. The esterification process is completed by adding diethyl ether 
to the reaction mixture. The isolated product is then heated with water to remove 
residual chloric (VII) acid. The product obtained in this way is treated for 24 hours 
with acetone, in which only di-butyrylchitin is dissolved. Then, the solution is 
concentrated to 5–6%. After the desired concentration is reached, the solution is 
poured into deionized water to precipitate the polymer, then the product is dried to 
obtain solid di-butyryl chitin. The above-described process of chitin esterification 
allows the conversion of free hydroxyl groups on the C3 and C6 carbon of the chitin 
into ester groups (CH3(CH2)2CO- substituent). Di-butyrylchitin is composed of di-
butyl-N-acetyl-amino-glucose units linked by 1,4-β-glycosidic bonds. The polymer 
is stabilized by hydrogen bonds between the polymer chains. Hydrogen bonds are 
formed with the participation of the hydrogen atom from the acetylamino group 
and the oxygen atom from the ester group. This kind of intermolecular interac-
tion determines its good mechanical properties [12–15]. Di-butyrylchitin does 
not dissolve and does not swell in water, but it dissolves in many organic solvents 
such as: acetone, methanol, ethanol, tetrahydrofuran (THF), dimethylformamide 
(DMF), chloroform, methylene chloride and others. Di-butyryl chitin is not easily 
degraded, it is resistant to γ-radiation (possibility of radiation sterilization), while 
enzymatic degradation under the influence of lysozyme and CE econase occurs at a 
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slow rate, which causes a slight change in molecular weight. Di-butyrylchitin with 
a molecular weight above 100000 Da has film-forming and fiber-forming proper-
ties [1, 2, 12–15]. Thus, obtaining DBC with the desired molecular weights directly 
determines its further processing capabilities (in particular electrospinning and 
leaching). The most important biological parameters of di-butyrylchitin are: pro-
longation of blood clotting time and good wettability. The use of DBC dressings has 
a positive effect on the granulation process (increasing the level of glycosaminogly-
cans in the wound), collagen cross-linking (generating more durable tissue), accel-
erating the wound healing process to form a healthy epidermis without scarring and 
protecting the wound against excessive moisture loss (optimal moist environment) 
[1, 2, 6–11]. In the course of treatment, the dressing slowly bio-degrades and 
resorbs until it disappears completely, which eliminates the painful act of changing 
it. The spontaneous, anti-pain effect of the dressing was also noted. DBC does not 
show cytotoxicity or irritation, it is a biocompatible polymer [9]. Di-butyrylchitin 
fibers are obtained by two methods: wet and dry-wet. The choice of the method 
used determines the structure of the obtained fibers. The fibers obtained in the 
wet-spinning process are less regular in shape, with a greater surface development 
than in the case of dry-wet spinning. DBC fibers produced by wet spinning are used 
as a raw material for the production of nonwovens. The technique of producing 
nonwovens from DBC depends on cutting the fibers into 6 cm long sections, from 
which the fleece is produced using a mechanical method on carding machines, and 
then the fibers in the fleece are joined by needling and calendaring [16, 17].
The dry-wet method of forming fibers from DBC hinges on preparing a spin-
ning solution with a concentration of 15 to 25% in ethanol, heating it to 60°C and 
squeezing it through a spinning die. Then, the incompletely solidified fiber is 
introduced into a water bath, where it is completely solidified. The fiber is then 
wound onto drums, stretched, and dried. A microporous DBC fiber with a linear 
mass of 1.7 to 5.6 g is obtained, depending on the concentration of the spinning 
solution used. The fibers obtained by the dry method have an elongated and curved 
cross-sectional shape, similar to a croissant. The degree of crystallinity of the fibers 
determined in X-ray examinations is similar in both methods and amounts to 
approx. 19%, and the transverse dimension of the crystallites approx. 23 Å. It is also 
easy to obtain chitin materials (the so-called regenerated chitin) from these materi-
als without damaging their macro-structure after a mild alkaline treatment. Fibers 
made of regenerated chitin and di-butyrylchitin do not induce cytotoxic, haemo-
lytic or irritating effects and cause minimal local tissue reaction after implantation 
[17–19]. Di-butyrylchitin and regenerated chitin fibers can be used to obtain dry 
dressing materials, as well as materials for other biomedical purposes. DBC-based 
woven dressings are biodegradable within the wound and do not need to be 
replaced during use [16, 17]. Chitin di-pentanoate (chitin divalerate, Di-O-Valeryl-
Chitin, DVCH) is also used for the production of commercially available dressings, 
where chitin is esterified with two valeryl groups (CH3(CH2)3CO- substituent) at 
the 3 and 6 positions of N-acetylglucosamine units. The high degree of DVCH 
esterification was achieved by using a large excess of valeric anhydride used both as 
acylating agent and reaction medium, and perchloric acid as catalyst. It turned out 
to be optimal to conduct the reaction where the molar ratio of valeric acid anhy-
dride to chitin was 7:1, which also facilitated thorough mixing of the components 
during the reaction and temperature control. The performance of the reaction 
under conditions of high homogeneity of the solution has a great influence on the 
quality of the product. Insufficient mixing of the solution during the acylation step 
led to a local temperature rise, uneven chitin acylation and ultimately resulted in 
products with varying degrees of esterification and higher polydispersity. 
Additionally, at elevated temperature it was observed reduction of the molecular 
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weight of the biopolymer as a result of the acidic degradation of chitin that occurs 
in parallel with the acylation reaction in the presence of a strong acid. To obtain 
products with a high degree of esterification, 0.5 M perchloric acid was used 
(deacetylation of the N-acetyl group was not observed). The separation of the raw 
product from the reaction mixture takes place during the neutralization of the 
valeric acid excess with a 2.5% NaHCO3 solution. The use of sodium bicarbonate as 
a weak base prevents deacetylation of the N-acetyl group. Depending on the 
reaction time and temperature, products with different parameters are obtained. 
The lower temperature leads to a product with a higher molecular weight. A longer 
reaction time increases the yield of the reaction, but is associated with a reduction 
in molecular weight due to acidic degradation of the polymer. The DVCH polydis-
persity index ranged from 1.47 to 2.06, suggesting a low molecular weight distribu-
tion. Due to the good solubility of DVCH in organic solvents such as acetone or 
ethanol, it is possible to prepare thin polymer layers by casting or porous structures 
by salt leaching. The DVCH shows a semi-ductile behavior and breaks when it 
exceeds the yield point. The stretching properties of DVCH films depend on the 
molecular weight. The modulus, yield stress, tensile stress as well as strain at break 
increase continuously with increasing DVCH molecular weight. The increase in the 
modulus with molecular weight results in higher mechanical strength of DVCH 
films. The elongation at break, although slightly increases with increasing molecu-
lar weight, remains low, not exceeding 4%. As a consequence, the higher DVCH 
molecular weight is, it behaves like a stiff plastic that can withstand relatively high 
stresses but does not withstand high elongation before breakage. Using the salt 
leach method, it is also possible to develop porous materials from DVCH. The 
structure of porous DVCH-based materials consists of a unified network of inter-
connected channels. This structure is characterized by a high content of open pores 
of various sizes. Two pore populations can be distinguished: large with a size in the 
range 150–780 μm (average pore size approx. 435 μm ± 168 μm) and small with a 
size in the range of 4–22 μm (average pore size 7.7 μm ± 3.3 μm [16–19]. Chitin 
divalerate is a technologically friendly biopolymer. The good solubility of DVCH in 
organic solvents (ethanol, DMAC, DMSO, acetone) due to the presence of hydro-
phobic valeryl groups in C-3 and C-6 positions enables its easy processing of its 
particles. The DVCH maintains the film-forming ability of chitin, so it can easily be 
used in the production of threads, films, foams and scaffolds, as well as non-woven 
fabrics. Biological data show that DVCH is not cytotoxic to fibroblasts and does not 
cause irritation or allergy to the skin of animals [20]. For the synthesis of chitin 
dihexanoate (DHCH) it is also possible to use appropriate acid anhydrides and 
methanesulfonic acid as a catalyst. In order to increase the homogeneity of the 
solution and better control the temperature in the process, by analogy to the 
synthesis of the valerate ester, an excess of acid anhydride and methanesulfonic 
acid are used, the mixture being the reagents and the reaction medium. Optimal 
methanesulfonic acid to chitin molar ratios are 16:1 and 10:1 for chitin di-hexanoate 
and chitin di-butyrate, respectively. This approach will result in a high degree of 
substitution of hydroxyl groups, equal to almost 2, and a low polydispersity. 
Moreover, under optimal conditions, no hydrolysis of the N-acetyl bond was 
observed. Good chitin solubility in methanesulfonic acid, even at low temperatures, 
allows the esterification process to be carried out under milder conditions. The key 
parameter is the intensity of agitation of the reaction suspension. Insufficient heat 
transfer due to poor mixing of the solution, similar to the synthesis of chitin 
di-pentanoate, leads to a lower degree of esterification, high polydispersity of the 
final product and a reduction in molecular weight. The neutralization process is 
carried out with a 4% sodium bicarbonate solution. The synthesis of DBC at a low 
temperature and short reaction time (temperature 0°C and 8°C) is ineffective due 
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to the low reaction yields and possibly incomplete esterification of the chitin 
hydroxyl groups, resulting in the formation of a significant amount of insoluble gel 
fractions when dissolved in acetone prior to precipitation with water. For DHCH, it 
is preferable to use low synthesis temperatures (0°C and 8°C). The yield of DHCH 
synthesis was relatively high (above 70%), with the highest efficiency observed at 
21°C (84 to 95%). Unfortunately, carrying out the synthesis of DHCH at 21°C 
resulted in a low molecular weight product. A trend analogous to that of chitin 
di-pentanoate was observed, indicating that the longer the reaction time, the higher 
the reaction performance and the lower the molecular weight of the obtained 
biopolymers. Although in DHCH the hydroxyl groups of chitin are substituted with 
longer alkyl chains than in DVCH or DBC, it has been found that DHCH retains 
good solubility in solvents such as ethanol, acetone, dichloromethane, 1,2-dichloro-
ethane, N,N-dimethylformamide, N,N-dimethylacetamide and ethyl acetate and no 
solubility in water. Good solubility, filmogenic and fiber-forming properties of 
DHCH give greater possibilities of its processing (film casting, washing method, 
electrospinning method) compared to chitin alone. The mechanical properties of 
DHCH and DBC in the form of thin solid layers poured from solution were investi-
gated in relation to their molecular weights. DHCH and DBC showed semi- 
continuous properties and cracked rapidly upon exceeding the plasticity point, 
similar to that observed for DVCH. The elongation at break was small and did not 
exceed 4%. For both biopolymers, their tensile properties correlate with the 
molecular weight. Parameters such as modulus of elasticity, stress at yield, as well as 
stress and strain at break, were found to increase with increasing DHCH and DBC 
molecular weight. Comparing the mechanical properties of DHCH, DBC and 
DVCH, it can be concluded that Young’s modulus decreases with increasing chain 
length of the acyl group of chitin diesters (a similar relationship is observed for 
chitin monoesters, where only one hydroxyl group is acylated). Due to the good 
solubility of hydrophobic chitin diesters in organic solvents and their insolubility in 
water, it is possible to obtain porous structures based on DHCH and DBC by using 
the salt leaching method. The prepared porous materials are characterized by a 
united network of interconnected channels and a high degree of open porosity with 
pores of various sizes (pore size in the range 78–421 μm, average pore size 
253 μm ± 93 μm) [21–24]. Due to its physic-chemical properties, DHCH can suc-
cessfully replace or support materials based on di-butyrylchitin (e.g. in the form of 
mixtures of both biopolymers) and thus it can be used as a material for medical and 
pharmaceutical applications, especially in tissue engineering scaffolds and in 
healing wounds. The described procedure of chitin esterification to obtain products 
of high purity. Moreover, this method is universal (the possibility of preparation 
various chitin diesters) and is easy to produce and is not time-consuming [21]. 
Another method of chemical modification of chitin is esterification leading to 
carboxymethylchitin (CMCht, CM-chitin) [22, 23] or dicarboxymethylchitin using 
monochloroacetic or mono-chloropropionic acid followed by  substitution of 
halogen with a hydroxyl group. This modification leads to the loss of the supramo-
lecular structure of chitin and the formation of water-soluble  derivatives [24].
2.2 Mixed chitin esters (co-esters)
The presence of two hydroxyl groups at the C-3 and C-6 positions of chitin 
allows the introduction of two different acyl substituents, leading to the formation 
of mixed esters (co-esters) of chitin. This possibility is also due to the differential 
reactivity of the hydroxyl groups linked to the primary and secondary carbon atoms 
in chitin. Thus, under ideal conditions, it is possible to obtain mixed esters con-
taining the same molar fraction of different acyl groups in the modified material. 
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Different ester groups (e.g., butyric and acetic acid residues) are present in mixed 
esters in a single polysaccharide chain. The replacement of some large bulky butyl 
groups with much smaller acetate groups in one polysaccharide chain causes that in 
a condensed state, it becomes possible to obtain favorable conditions for the forma-
tion of intermolecular bonds of the hydrogen bridge type. This effect cannot be 
expected when using a mixture of two different biopolymers (e.g. chitin diacetate 
and chitin di-butyrate). Thus, the term mixed polymers is not the same as mixed 
chitin esters. In order to obtain a polymer mixture, it is necessary to use at least two 
chemically different polymers (Figure 2). In contrast mixed ester/co-ester of chitin 
contains only one component. It was found that the differences between chitin 
mixed esters (co-esters) and a mixture of two species can be observed in NMR 
spectra (1H and 13C) (Figures 3 and 4). The studies used 50:50 butyryl-acetyl-chitin 
co-polyester (2) (mixed ester), 90:10 butyryl-acetyl-chitin co-polyester (3) and a 1: 
1 mixture of chitin di-butyrate (1) and chitin diacetate (4).
A comparative analysis of the 13C-NMR spectra of the 180–150 ppm range 
characteristic for the chemical shifts of carbon in carboxylic acid derivatives 
showed that the distribution in the mixed ester of chitin 2 and 3 is different from 
the carbon signals of the 1: 1 mixture of polymers 1 and 4 (Figure 3). A similar 
result is observed in the range of 10–40 ppm, characteristic for carbons of aliphatic 
ester residues introduced as a result of esterification of chitin with acetic anhydride 
and butyric acid (Figure 3).
Comparative studies of 1H-NMR spectra in the range of chemical shifts 2.5 ppm 
to 0.5 ppm also allowed to state that in the case of butyryl-acetyl chitin co-polyes-
ters (samples 2 and 3) the recorded signals are different than in the case of the 1: 1 
mixture of polymers 1 and 4 (Figure 4).
The possibility of forming the intermolecular hydrogen bonds that stabilize 
butyryl-acetyl chitin co-polyester structure translates into fiber-forming properties, 
and thus the possibility of modulating the functional properties of the final materi-
als and their use in the manufacture of new materials for medical use. In addition to 
stabilization by hydrogen bonds, it is also possible to create weak interactions based 
on hydrophobic interactions. The participation of such various weak interactions 
in the stabilization of materials may translate into their ability to interact with both 
hydrophobic and hydrophilic structures, which affects biological activity.
2.2.1 Chitin co-esters in dressing materials
Acetate-formate mixed chitin ester was obtained using formic acid, acetic 
anhydride and trifluoroacetic acid as a catalyst [25]. It turned out that this ester 
is slightly soluble in typical organic solvents. This is one of the reasons why this 
derivative has not found practical use, even though its biological properties are 
comparable to those of chitin. A similar situation was observed in the case of 
trifluoroacetate-formate derivatives of chitin [26].
Attempts to obtain a mixed butyric acetic ester of chitin by reaction using acetic 
and butyric anhydrides and methanesulfonic acid or trifluoroacetic acid as catalysts 
have been unsuccessful. The final product was a mixture of chitin acetate, chitin 
butyrate and the expected acetate-butyrate of chitin [27, 28].
The approach to synthesize mixed chitin esters using a mixture of trifluoro-
acetic acid and the corresponding organic acid as catalysts also led to the forma-
tion of mixtures of chitin monoesters and mixed esters (co-polyesters) of chitin. 
It has been shown that carrying out the reaction at the temperature of 70°C for a 
short time (30 min) under homogeneous conditions allows for obtaining co-
polyesters: acetate-butyrate, acetate-hexanoate, acetate-octanoate and acetate-
palmitate of chitin. The final co-polyesters have molecular weights ranging from 
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Figure 3. 
Fragments of 13C-NMR spectra of 1, 2, 3 and 4 derivatives.
Figure 2. 
Chemical structure of chitin di-acetate, chitin di-butyrate, butyryl-acetyl chitin co-polyester (mixture ester, 
co-ester).
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30 to 150 kDa and the degree of esterification ranging from 1.0 to 2.0, depending 
on the raw materials used.
Another approach to obtain mixed butyryl-acetyl esters of chitin [29] is based on 
the use of butyric and acetic acid anhydrides and methanesulfonic acid as a catalyst. 
However, this method is not very friendly from the point of view of industrial stop-
page. Thinking about the industrial synthesis of the butyryl-acetyl chitin derivative, 
it was necessary to establish reaction conditions that would eliminate the need to 
use methanesulfonic acid.
In the works on the development of a method for the production of the butyryl-
acetyl chitin co-polyester on an industrial scale, it was necessary to develop, in the 
first stage, the conditions for the synthesis on a laboratory scale, which would later 
be transferred to an industrial scale. The esterification in laboratory conditions is 
carried out under heterogeneous conditions at 20-25°C, using chloric (VI) acid as 
a catalyst and a mixture of butyric and acetic acid anhydrides, used in a molar ratio 
of 90:10 [22, 23]. The product was obtained with a yield of 82 to 89% is soluble in 
DMF, DMSO and NMP, has a high molar mass (intrinsic viscosity of these products 
determined in DMF at the level of 2.0–2.05 dL/g) and a full degree of esterifica-
tion. In the research on the development of a method of producing butyryl-acetyl 
chitin co-polyester in industrial conditions it was crucial to eliminate the possibility 
of formation an explosive mixture which may arise as a result of direct contact of 
acetic anhydride with perchloric acid. It turned out that the priority was to use an 
efficient cooling system so that the process temperature did not exceed 20°C. In 
laboratory conditions, it was sufficient to use an ice-water bath with NaCl (brine 
bath) and intensive mixing of the suspension. In laboratory conditions, diethyl 
ether is added to the slurry to remove excess unreacted anhydrides and formed 
carboxylic acids and the crude product is filtered off. The crude acetylation product 
is washed with water and dilute ammonia water, dried and finally dissolved in 
ethanol. The transfer of the conditions from the laboratory scale to the macro scale 
Figure 4. 
Fragments of 1H-NMR spectra of 1, 2, 3 and 4 derivatives in the range 2.5–0.5 ppm.
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did not involve only increasing the amount of reagents and the size of the synthe-
sizer. The key was to optimize the process conditions and the use of reagents that 
can be used in industrial conditions from the point of view of safety, environmental 
impact and economics. A reactor with a capacity of 60 dm3 with an effective cooling 
system was used. A 3 kg chitin input was used for the synthesis. The remaining 
reagents (2 dm3 of perchloric acid, 15 dm3 of butyric anhydride and 1 dm3 of acetic 
anhydride) were added in portions. The time required for all reagents to be intro-
duced and for complete conversion was about 24 h. In place of diethyl ether, under 
industrial conditions, ethyl acetate was used to remove excess unreacted butyric 
and acetic anhydrides. In industrial conditions it was also necessary to replace the 
ammonia water to neutralize the acetic and butyric acid residues. It turned out that 
it is possible to use sodium carbonate for this purpose. Also, the step of separation 
of raw product required changes in the industrial process. In the synthesis under 
laboratory conditions, G4 Schott funnels were used for filtration. However, the use 
of this method on a large scale was ineffective. So suction filtration was used, the 
efficiency of which was 100 dm3 per hour. The process efficiency on an industrial 
scale was comparable to that of a laboratory scale synthesis. The physical and 
chemical properties of the final products were also comparable. The conducted 
research guaranteed the reproducible and required parameters of the raw material 
for the production of new medical materials [22, 23]. Figure 5 shows a set for the 
synthesis of butyryl-acetyl chitin co-polyester on an industrial scale.
The development of an efficient synthesis of the butyryl-acetyl chitin co-polyes-
ter (BAC 90/10) made it possible to demonstrate that the obtained chitin derivative 
has the ability to form fibers from a wet solution with a strength slightly above 20 
cN/tex with high porosity. Fibers with a strength at this level can be the basis for 
the production of 3D polymer-fiber composites. BAC 90/10 fibers show a stronger 
predisposition to apatite crystallization; strong sorption tendencies of fibers allow-
ing the possibility of local supersaturation favoring the nucleation of apatite. It has 
been also found that BAC 90/10 fibers degrade fast under in vitro conditions.
One application of the butyryl-acetyl chitin co-polyester (BAC 90/10) is its use 
to produce highly porous film materials [30].
The research work began with laboratory tests during which two methods of for-
mation of porous materials were tested: (a) pouring a 5% ethanol BAC 90/10 solu-
tion on a layer of solid inorganic salt (porophor agent), which, after solidification, 
was exposed to water to wash out the porophor agent, and (b) the use of porophor 
Figure 5. 
Set for the synthesis of butyryl-acetyl chitin co-polyester on an industrial scale.
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agent suspensions in BAC 90/10 solution, which was a mixture of solvents with a 
density close to the bulk density of the porophor agent. Various organic and inor-
ganic salts (K2CO3, KHCO3, KHSO4, KNO2, (NH4)2CO3, (NH4)HCO3, (NH4)2HPO4, 
(NH4)2SO4, Na2CO3, NaHCO3, Na2HPO4, Na2S2O3 x 5H2O, NaCl, di-ammonium 
citrate, di-ammonium oxalate were tested. It was found that all tested salts can be 
used as porophors. However, the most optimal porophor agent, in terms of porosity 
(95–99%) and tensile strength of 5 cN, was NaCl.
Based on laboratory work, it was possible to start work on optimizing the 
production of porous dressing materials (Medisorb R, Medisorb R Ag). In the 
industrial method, solid NaCl as porophor agents and a 3% solution of BAC 90/10 
in ethanol were used. The membrane was formed by pouring a 3% solution of 
BAC 90/10 onto a layer of porophor agent to produce a spongy structure. After 
drying, the membrane is rinsed in distilled water at 40°C until the porophor agent 
is washed off. The product is then dried at 80°C. After packing, the obtained 
membrane dressings are subjected to a process of radiation sterilization (in the 
case of the variant without the addition of an antibacterial substance). To obtain 
a silver-coated membrane, the membrane is sprayed with a suspension of metallic 
silver dispersed in water by means of a spray nozzle. The silver particles are evenly 
distributed in the suspension using an ultrasonic device. After drying and then 
packing, the product is subjected to radiation sterilization. The powder dressing is 
obtained by grinding the byturyl-acetyl chitin co-polyester, which is then sterilized 
by radiation [23, 31]. Figure 6 shows a scheme for the preparation of porous  
dressings based on butyryl-acetyl chitin co-polyester.
Dressing materials obtained by leaching salt from butyryl-acetyl chitin co-
polyester (BAC 90/10) and sodium chloride with a diameter of 0.16–0.40 nm and/
or microsilver were characterized by a high degree of porosity, pore size in the 
range of 275–305 nm and a degree of crystallinity in the range of 27.2–27.4%. SEM 
Figure 6. 
A scheme for the preparation of porous dressings based on butyryl-acetyl chitin co-polyester.
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tests confirmed the porous structure of pores, which are negative for the crystals 
of the inorganic porophor agent used. In addition, the pores are open pores, which 
increases the effectiveness of water adsorption. Figure 7 shows microscopic picture 
of porous structures obtained by the porophor agent washout method.
Dressings made of butyryl-acetyl chitin co-polyester (Figure 8) are intended for 
wounds of various etiologies, including chronic wounds, where the healing process 
is disturbed by comorbidities. In order to accelerate the healing of deep wounds, 
a dressing in the form of a backfill has been designed. Wounds are often accom-
panied by a bacterial infection, therefore, apart from the dressing in the form of a 
membrane made of chitin co-polyester only, there is also a variant containing the 
addition of silver, showing a bactericidal effect in the wound environment. Silver 
may appear in various forms, however, it has been assumed that only the ionic form 
of silver has a bactericidal effect. Any other form of silver must be converted to 
its ionic form. Hence, metallic silver with a small particle size after oxidation and 
hydrolysis is characterized by the highest antibacterial activity. Silver in ionic form 
also has the ability to interact with proteins. It has been found that the ionic form of 
silver has a higher protein binding capacity compared to nanoparticles [32–36].
The presence of pores and microcapillaries in the structure of membrane 
dressings allows drainage of wound exudate. Dressings made on the basis of chitin 
co-polyesters are characterized by high biocompatibility. Biological tests confirmed 
the lack of cytotoxic, irritating and allergenic effects. These dressings are degraded 
Figure 7. 
Microscopic picture of porous structures obtained by the porophor agent washout method.
Figure 8. 
Picture of porous structures obtained by the porophor agent washout method.
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in the subcutaneous tissue and gradually become smaller. The dressing shortens 
and weakens the exudative phase, drains the wound and accelerates the productive 
phase. The epithelialization process under the butyryl-acetyl chitin co-polyester 
was completed faster compared to the control sample [37].
FTIR ATR analysis was made for samples of untreated Medisorb R dressings 
and material treated with fresh human plasma in order to test the dressing surface 
degradation and protein absorption on the dressing surface. Comparing spectra 
of samples treated with fresh human plasma and pure material, the decreasing of 
intensity of the vibration band of C=O at 1733 cm−1 in relation to the amide I signal 
at 1659 cm−1 was observed. It confirmed the sample surface degradation, which 
was connected to the hydrolysis of ester BAC 90/10 groups. In the in vivo tests, the 
dressings under macroscopic examination, in full thickness defects of subcutaneous 
tissue and skin caused wound healing with no inflammation, undergoing the most 
gradual biodegradation between weeks 4 and 8, and the observed differences were 
statistically significant [37].
The developed biodegradable dressings based on butyryl-acetyl chitin co-poly-
ester were subjected to clinical evaluation using a wide range of patients. The use 
of dressings significantly accelerated the wound healing process caused by venous 
insufficiency and diabetes, also in patients whose healing process was disturbed by 
comorbidities. The improvement of the clinical condition of the wound depends on 
the individual patient and is most often observed after 30–60 days. The obtained 
results indicate that the tested dressings significantly reduce the time of wound 
healing. Medisorb R Ag is more effective than Medisorb R Membrane in the treat-
ment of infected wounds. The powder form (Medisorb R Powder) allows the appli-
cation of the dressing to deeper wounds. Thanks to their unique structure, dressings 
drain wound exudates beyond its environment, thus restoring the proper course of 
the cell reconstruction process. The ability to biodegrade in contact with the wound 
secretion eliminates the need to replace dressings, so the newly formed granulation 
tissue is not disturbed - cell reconstruction processes run smoothly [38].
3. Chitosan- raw materials obtained from chitin
Chitosan is obtained as a result of the hydrolysis of chitin N-acetylamide groups 
(partial deacetylation of chitin). The main advantage of chitosan is its much better 
solubility in aqueous acid solutions, especially organic acids. Chitin deacetylation 
by chemical or enzymatic methods allows for obtaining materials with various 
degrees of hydrolysis (Figure 9). However, it is assumed that at least 50% chitin 
deacetylation is necessary for the material to be classified as chitosan. The degree 
of deacetylation (DD) is defined as the ratio of the number of free NH2 groups to 













where N - the number of specific units (structural units) in the polymer.
The value of DD affects the biological and physicochemical properties of the 
polymer, such as solubility, swelling and stability, as well as reactivity.
Chitosan obtained by chemical (concentrated NaOH) or enzymatic (chitin 
deacetylase) deacetylation of chitin. The first step of preparation of chitosan 
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is mechanical grinding of the raw chitin, and subsequent process of removing 
proteins, color compounds and inorganic salts takes place. The deproteinization 
process is usually performed with a dilute aqueous solution of sodium hydroxide at 
an elevated temperature [4, 5]. For protein removing also proteolytic enzymes were 
used [39, 40], but in the case of papain, trypsin and chymotrypsin, it was found 
that they did not completely remove the protein fraction. After deproteinization 
process, the residue is treated with dilute aqueous hydrochloric acid to dissolve 
the calcium carbonate. A similar effect can be obtained by using HCOOH, HNO3, 
H2SO4 or EDTA [5]. The decolorization process is based on extraction with etha-
nol, acetone or treatment with oxidizing reagents (KMnO4, NaOCl, H2O2). These 
activities allow to obtain chitin of required purity for its further transformation 
into chitosan. Chitosan from chitin obtained by chemical deacetylation is obtained 
at high temperature (above 100°C), under high pressure and in the presence of 
concentrated (40–50%) strong bases (usually NaOH). A typical industrial chitosan 
production process provides almost complete recovery of proteins, calcium oxide 
or calcium carbonate, carotenoid pigments and sodium acetate under the condi-
tions of using sodium hydroxide as the deacetylating agent. However, this process 
has several disadvantages. It is not environmentally friendly as it consumes a 
large amount of energy and is also difficult to control leading to a heterogeneous 
product. The use of chitin deacetylase for the production of chitosan oligomers 
and polymers can potentially eliminate most of these drawbacks [41]. The advan-
tages of enzymatic deacetylation are more pronounced in the processing of chitin 
oligomers, as these substrates are soluble in the aqueous medium and are therefore 
more susceptible to enzymes. The downside is the high cost of the enzyme and the 
requirement to use pre-processed chitin. The conditions of the chitin deacetylation 
process have a significant impact on the distribution of N-acetyl-D-glucosamine 
and D-glucosamine groups in the polysaccharide chain. Their location in the chain 
has a significant impact on the physicochemical properties of the material, such as 
crystallinity, solubility and susceptibility to degradation [3]. Depending on the final 
use, chitosan can be formed into a hydrogel, membranes, fibers, sponges and micro/
nanoparticles [42].
Figure 9. 
Chitosan formation from chitin by chitin deacetylation.
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4. Chitosan parameters
4.1 Physio-mechanical parameters of chitosan
Chitosan is a polysaccharide composed of randomly distributed acetylated and 
deacetylated units of D-glucosamine. Chitosan exists in five different crystal forms, 
four of which are hydrated and one is anhydrous. Microcrystalline chitosan is 
characterized by better biodegradability and bioactivity.
Most of the properties of chitosan depend on two parameters: degree of 
deacetylation and molecular weight distribution. Depending on the source and 
method of preparation, the deacetylation degree varies from 30 to 95%, and the 
molecular weight from 300 to over 1000 kDa [43]. The solubility of chitosan 
strongly depends on the deacetylation degree, which translates into the number of 
free amino groups. Chitosan is soluble in acidic solutions due to its susceptibility 
to protonation and formation of ammonium salts. It is soluble in acetic, formic, 
citric, lactic and hydrochloric acid and insoluble in most organic solvents. Chitosan, 
as a biodegradable polymer, is easily broken down by microorganisms into simple 
chemical compounds such as carbon dioxide (CO2) and ammonia (NH3). Like other 
biopolymers, it is susceptible to many chemical and physical factors leading to its 
degradation. The degradation process also depends on the degree of deacetylation 
and the molecular weight of the polymer [3, 5].
Chitosan has many valuable properties, such as: biocompatibility, biodegrad-
ability, non-toxicity, the ability to create polycations in an acidic environment, 
the possibility of modification, high affinity for metals, dyes and proteins, hydro-
philicity, ability to create membranes and others [3, 5, 44]. These features make it 
applicable in medicine and pharmacy, in various industries, in environmental pro-
tection, including water treatment and separation processes. [5, 45, 46]. Chitosan 
also has a number of properties that limit its use in certain areas. It swells strongly 
in water (especially in an acidic environment), and in the swollen state it is char-
acterized by low mechanical strength. The use of chitosan is also limited due to its 
high viscosity. The reduction of the viscosity of chitosan solutions can be achieved 
by increasing the deacetylation degree while reducing the molecular weight and 
increasing the temperature or ionic strength [5, 47]. The key problem with the use 
of chitosan is its susceptibility to external factors (humidity and temperature) 
and processing conditions (heating or sterilization), which can affect its structure 
and cause its degradation. Parameters such as molecular weight or the presence 
of impurities have a significant impact on the processing of chitosan [48]. This 
causes difficulties in maintaining the stability of chitosan (no changes in molecular 
weight) for a long time at room temperature [49]. The influence of many factors, 
such as increased temperature, the presence of strong acids, mechanical shear or 
radiation, on the molecular weight of chitosan was demonstrated. It is also believed 
that high molecular weight chitosan is more stable. The lack of reproducibility in 
the processing of chitosan is also due to significant differences in molecular weight, 
deacetylation degree and purity level depending on the source of the raw material. 
The level of chitosan purity may affect both biological properties, such as biode-
gradability or immunogenicity, as well as its solubility and stability [48, 50].
4.2 Biological parameters of chitosan
Chitosan is a non-toxic polysaccharide containing randomly distributed acety-
lated and deacetylated units of D-glucosamine. The results of many studies confirm 
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the antibacterial effect of chitosan. The mechanism explaining this feature is 
unknown [51]. The antimicrobial activity of chitosan is strongly dependent on many 
factors, such as molecular weight [52], degree of deacetylation (DD), pH of the dis-
solving medium and its ionic strength. Stronger antibacterial activity was observed 
with a high degree of deacetylation [53] and a low molecular weight of chitosan [54]. 
The antibacterial activity of chitosan is also associated with the form of the polymer 
(hydrogels, membranes, dissolved form) and the presence of other compounds [55]. 
One of the factors responsible for the antibacterial activity of chitosan is its cationic 
nature. The positively charged ammonium groups of chitosan may interact with 
negatively charged components of the bacterial cell wall, causing damage to the 
cell membrane and destruction of bacterial cells (a mechanism proposed for high 
molecular weight chitosan) [56]. Ultimately, this causes the formation of an imper-
meable layer around the bacterial cell, affecting permeability and transport to the 
cell [57, 58]. It has been suggested that low molecular weight chitosan can penetrate 
bacterial cell walls and eventually enter the cytoplasm and bind to DNA affecting 
DNA transcription, mRNA synthesis and finally protein biosynthesis [59].
The difference in the hydrophilicity and the negative charge of the cell surface 
of the bacteria makes gram-negative bacteria interact more strongly with chitosan, 
resulting in higher antibacterial activity against them.
The antibacterial activity of chitosan or its derivatives on gram-negative bacteria 
has been demonstrated for various strains: Escherichia coli, E. coli K88, E. coli ATCC 
25922, E. coli O157, Pseudomonas aeruginosa, Proteus mirabilis, Salmonella enter-
itidis, S. choleraesuis ATCC 50020, S. typhimurium, S. typhimurium ATCC 50013, 
Enterobacter aerogenes, Listeria monocytogenes [60–64]. The antibacterial activity 
of chitosan or its derivatives on gram-positive bacteria has been demonstrated 
for: Staphylococcus aureus, S. aureus ATCC 25923, Corynebacterium, Staphylococcus 
epidermidis, Enterococcus faecalis, Bacillus cereus, Bacillus megaterium. This indicates 
a broad spectrum of chitosan activity. It was also found that the effectiveness of 
chitosan binding to the bacterial cell wall depends on the pH value. At low pH, chi-
tosan shows better adsorption to the bacterial cell wall due to the increased positive 
charge of protonated amino groups [65–67].
The antifungal activity of chitosan also depends on its molecular weight and 
degree of acetylation. It was found that chitosan shows antifungal activity against 
selected phytopathogenic fungi Penicillium sp. in citrus [68], Botrytis cinerea in 
cucumber [69], Phytophthora infestans [70], Alternaria solani and Fusarium oxyspo-
rum [71]. Chitosan is also active against fungal species pathogenic to humans, while 
being non-toxic to human cells. The antifungal activity of chitosan or its derivatives 
has been demonstrated against: Candida albicans, Candida parapsilosis, Candida 
krusei, Candida glabrata, Penicillium digitatum, Penicillium italicum, Fusarium 
proliferatum, Hamigera avellanea, Aspergillus fumigatus, Rhizopus stolonifer, Cryptus 
stolofattans. The suggested mechanism of action is to create a permeable layer by 
chitosan which disrupts fungal growth [72–75]. It is believed to be related to the 
activation of defense processes, including chitinse accumulation, synthesis of 
proteinase inhibitors, callus synthesis and the lignification process [76].
The antiviral activity of chitosan derivatives is also suggested. The research focuses 
mainly on HIV. Peptide-chitosan conjugates (GlnMetTrp-chitosan and TrpMetGln-
chitosan) show a protective effect on C8166 cells by counteracting the cytolytic effects 
of the HIV-1RF strain. These derivatives have the ability to suppress HIV-induced syn-
cytium formation and reduce HIV load without inhibiting HIV-1 reverse transcriptase 
and protease in vitro [77]. Sulfated low molecular weight chitosan derivatives inhibit 
HIV-1 replication, HIV-1 induced syncytium formation, lytic activity and p24 antigen 
production. These derivatives are believed to influence the binding of HIV-1 gp120 to 
the CD4 cell surface receptor [78]. In comparative studies, chitosan conjugates with 
17
Modulating the Physicochemical Properties of Chitin and Chitosan as a Method of Obtaining…
DOI: http://dx.doi.org/10.5772/intechopen.95815
thioglycolic acid, lactic acid, PEG and antiviral drugs, significantly higher efficacy 
was observed compared to the use of the drug alone [79–85].
Recent studies have shown that chitosan and its derivatives exhibit anti-tumor 
activity in both in vitro and in vivo models. It was found that chitosan derivatives 
increased the secretion of interleukin-1 and 2, influencing the maturation and 
infiltration of cytotoxic T lymphocytes [86]. The results have been confirmed in an 
in vivo study [87]. Moreover, a direct cytotoxic effect on neoplastic cells was found by 
inducing apoptosis. For A375, SKMEL28 and RPMI7951 cancer cell lines it was found 
to reduce cell adhesion, inhibit proliferation, inhibit specific caspases, regulate the 
activity of Bax as well as Bcl-2 and Bcl-XL, induce CD95 receptor expression through 
greater susceptibility to chitosan-induced apoptosis by FasL [88]. In the case of the 
PC3 A549, HepG2 and LCC cell lines, in the presence of chitosan, inhibition of the 
growth of neoplastic cells and inhibition of MMP-9 expression, hampering of cells 
in the S phase and reduction of the rate of DNA synthesis, p21 and PCNA regulation 
were found [89]. HepG2 and LCC xenografts in a mouse model showed inhibition 
of tumor growth and a reduction in the number of metastatic colonies at the dose 
of 500 mg/kg [90]. Carboxymethylated chitosan [91] inhibited hydrogen peroxide-
induced apoptosis in Schwann cells by reducing caspase-3, −9 and Bax activity and 
increasing Bcl-2 activity.
Various biological properties of chitosan also include good adhesion to cells, 
macrophage activation, stimulation of fibroblast proliferation, stimulation of 
cytokinin production, stimulation of type IV collagen synthesis, promoting angio-
genesis processes, haemostatic properties [92–95]. Moreover, it has a positive effect 
on granulation and epithelialization, and reduces scar formation. It is believed that 
many of the listed biological activities of chitosan are related to its unique feature, 
namely its cationic nature. Chitosan molecules with a positive charge interact with 
negatively charged erythrocytes and thrombocytes activating the extrinsic coagula-
tion, effectively stopping bleeding.
Chemical modification of chitosan allows to modulate the biological activity of 
chitosan, for example, heparin inactivation or antiviral activity. Chitosan can be 
in the form of: gel, sponge, fiber or porous composition with ceramics, collagen or 
gelatin. Chitosan is used as a component of wound healing dressings, while in the 
case of scaffolds, it is usually used with other natural polymers (hyaluronic acid, 
alginic acid, poly-L-lactidic acid, elastin, collagen, gelatin) or additives (hydroxy-
apatite, calcium phosphate, ceramic components) [95–97].
Chitosan increases the inflow of phagocytic cells (segmented granulocytes and 
macrophages) to the site of infection, stimulates the migration and proliferation of 
endothelial cells and fibroblasts. The effect of chitosan on the proliferation of fibro-
blasts depends on the degree of deacetylation and molecular weight. Forms with 
a higher degree of deacetylation and lower molecular weight stimulate fibroblast 
proliferation to a greater extent [98–123]. Chitosan is widely researched for its use 
in bone and cartilage reconstruction. It has the ability to create porous structures, 
which makes it used in tissue engineering, orthopedics and bone regeneration. It 
has also been used in drug delivery systems or therapeutic substances (DNA plas-
mids, siRNA, nanosilver), for the production of surgical sutures, wound healing 
dressings and artificial internal organs [124–150].
An interesting chitosan feature is also its ability to bind with mucus and cross 
epithelial barriers, so that its use as an adjuvant or auxiliary adjuvant in vaccines 
is considered. It is also included among the auxiliary substances that enable the 
preparation of various forms of drugs with specific properties.
It is an excellent metal ion complexing agent. This parameter is useful due to 
the immobilization of metal ions with antibacterial activity and enabling their 
 controlled release, depending on the needs [97].
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Chitosan can also be an environmentally friendly agent used to obtain textiles 
with antibacterial properties. Attempts were made to introduce chitosan powder into 
cotton and polyester-cotton fabric. Chitosan was introduced after the fabric surface 
was activated by 20% NaOH. The performed studies confirmed that chitosan is well 
implemented in fabrics made of a cotton and polyester/cotton blend [151].
4.3 Chitosan in dressing materials
Due to its physicochemical and biological properties, chitosan and its derivatives 
are considered to be versatile biomaterials with various biological activities [152–159].
Chitosan and its derivatives as materials with antimicrobial activity and low 
immunogenicity are widely used in wound healing. They provide a three-dimen-
sional matrix for tissue growth, activate macrophages and stimulate cell proliferation 
[160]. Chitosan improves the activity of polymorphonuclear leukocytes, macro-
phages and fibroblasts, which increase granulation and organization of repaired tis-
sues [161]. Its degradation to N-acetyl-β-D-glucosamine stimulates the proliferation 
of fibroblasts, supports regular collagen deposition, and also stimulates the synthesis 
of hyaluronic acid at the wound site. These properties accelerate healing and prevent 
scarring [162]. The development of chitosan formation in the form of nanofibers 
with the assumed adhesive properties allowed to obtain a material useful for the 
creation of dressing materials [163]. Chitosan nanofibers obtained by electrospin-
ning method are porous, have high tensile strength, large surface area combined with 
an ideal rate of water vapor and oxygen transfer. They are also compatible with stem 
cells derived from adipose tissue, which is beneficial for wound healing [164, 165].
A characteristic feature of chitosan dressings is their ability to effectively control 
bleeding [166]. The most important element of hemostasis is blood clotting, which 
leads to the formation of a clot consisting mainly of the fibrin network and platelets 
embedded in it. This process prevents further loss of fluid and electrolytes from 
the wound and reduces contamination of the wound. There is erythema around 
the wound, swelling, pain and locally increased temperature. Inflammation wid-
ens local blood vessels, which facilitates the penetration of macrophage cells and 
fibroblasts into the wound, which cleanse the wound of tissue residues, vascular 
clots and pathogenic bacteria. In the next phase of healing, fibroblasts synthesize 
collagen and other proteins needed to build and regenerate connective tissue and 
rebuild damaged blood vessels. In the course of scar formation, type III collagen 
fibers transform into type I collagen until they reach the balance characteristic 
of healthy skin and are necessary to restore skin continuity. The final remodeling 
process leads to a significant increase in the mechanical strength of the wound. 
The haemostatic effect of chitosan has been clearly documented. Chitosan in the 
form of a non-woven fabric has a positive effect on each stage of wound healing. 
The unique features of chitosan include: macrophage activation, stimulation of 
fibroblast proliferation, absorption of growth factors, stimulation of cytokinin 
production, stimulation of type IV collagen synthesis, support for angiogenesis 
processes, antibacterial and hemostatic properties. The positive effect of chitosan 
on granulation tissue, epidermis and reduction of scar formation has been proven. 
Like chitin, chitosan is susceptible to enzymatic biodegradation which produces 
biologically active oligosaccharides. The positively charged chitosan molecules react 
with negatively charged erythrocytes and thrombocytes to activate the external 
clotting pathway and effectively block bleeding. At the same time, chitosan can 
serve as a carrier of specific medicinal substances (DNA plasmids, siRNA, nanosil-
ver particles), which enhance its positive effect on the healing process. Chitosan has 
also been found to significantly increase the adhesion and aggregation of platelets in 
the process of hemostasis [167, 168].
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Currently, there are many chitosan materials available on the market that are 
used to heal wounds in patients undergoing plastic surgery [169], skin grafting 
[170, 171] and endoscopic sinus surgery [172]. Chitosan-containing materials in the 
form of nonwovens, nanofibers, composites, films and sponges are: HemCon®, 
GuardaCare®, ChitoFlex®, ChitoGauze®, Celox™ Granules, Celox™ Gauze, 
Chito-Seal™, Clo-SurPLUS PAD Tegasorb™, Tegaderm™ ChiGel, ChitopackC®, and 
TraumaStat™ [173–176].
Haemostatic dressings also include Tromboguard® - a multi-layer dressing made 
of three layers: semi-permeable polyurethane foil, hydrophilic polyurethane foam, 
and a layer containing chitosan. The film layer protects the dressing against seepage, 
allowing the wound environment to remain moist, ensuring optimal air permeabil-
ity to its interior and creating a barrier against external factors. Polyurethane foam 
is a load-bearing layer and has strong absorbent properties thanks to the “pore-in-
pore” structure. The polyurethane layer is responsible for storing exudate and keep-
ing it outside the wound surface, ensuring adequate wound moisture. Additionally, 
it is a layer that protects the wound against mechanical damage.
The active layer, which is created by a unique composition of chitosan and algi-
nates, activates the blood coagulation process, significantly reducing bleeding time. 
By reacting on the wound surface with erythro- and thrombocytes, chitosan signifi-
cantly shortens the bleeding time. Calcium alginate accelerates the natural clotting 
process, and sodium alginate - by absorbing wound discharge - creates a layer of gel 
on the surface of the dressing that prevents it from sticking to the wound. Alginates 
are resorbable, non-toxic, non-carcinogenic, non-allergic and haemostatic [177]. 
When used as dressing materials, it is important that during contact with the 
wound, part of the alginate dressing passes in the form of a gel, which prevents the 
wound surface from drying out, and thus creates the possibility of creating a favor-
able, moist environment within the skin lesion [178]. At the same time, hemostatic 
properties result in a faster wound healing process and allow for more effective 
scarring. Patients also benefit from using these dressings to reduce pain when 
changing them. A significant advantage of using alginate-containing dressings is 
the elimination of the dressing sticking to the wound and high absorbency.
The Tromboguard® dressing (Figure 10) is used to stop bleeding in the case of: 
traumatic wounds, postoperative wounds, skin graft collection sites in surgery and 
reconstructive surgery - including combustiology, wounds requiring emergency 
care, gunshot and puncture wounds, wounds resulting from traffic accidents. 
It is characterized by a quick hemostatic effect (stops bleeding in 3 minutes), an 
antibacterial effect inside the product (protecting the dressing against the growth 
of microorganisms), and effective blood absorption even under pressure. It is not 
irritating, sensitizing and cytotoxic.
Figure 10. 
Tromboguard® dressing structure.
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Tests of operational parameters: tensile strength, the ability to adapt to the 
injury site or the transmission of moisture vapors have shown that this dressing has 
a tensile strength (for porous materials) of min. 75 kPa (according to PN-EN ISO 
1798), which corresponds to the value recommended for dressing materials, and 
vapor permeability (transmission of moisture vapor) of min. 400 g/m3/24h.
The results of clinical trials have demonstrated the high haemostatic efficacy 
of Tromboguard®. The high effectiveness and durability of the antihaemorrhagic 
effect was confirmed 24 hours after application, which allowed the introduction 
of an absorbent foam dressing [179] and a three-layer hemostatic dressing to the 
market [96, 97].
5. Conclusion
Chitin and its ester derivatives, as well as chitosan obtained as a result of chitin 
deacetylation, have many valuable chemical, physical and biological properties that 
determine their use in many areas, also in medicine.
The widest use of chitin and its derivatives is observed in biomedical sciences, in 
particular: in dressing materials (active dressings), active substance carriers (drugs 
and growth factors), in tissue engineering (cell scaffolds - scaffolds, mainly ortho-
pedics) and in regenerative medicine (stem cell differentiation). Chitin accelerates 
the wound healing process by having a beneficial effect on processes such as angio-
genesis, granulation, epithelialization and scar formation, which play a key role 
in the physiological wound healing process. It increases the inflow of phagocytic 
cells (segmented granulocytes and macrophages) to the site of infection, stimulates 
the migration and proliferation of endothelial cells and fibroblasts. Chitin deriva-
tive dressings are considered to be very effective medical devices in the healing of 
difficult-to-heal wounds [6–11].
The results of clinical trials with dressings based on butyryl-acetyl chitin 
co-polyesters have also shown their high effectiveness in healing wounds of vari-
ous etiologies, mainly those caused by chronic venous insufficiency and diabetes. 
Their use leads to a reduction in the ulcer area and its depth. These dressings were 
assessed as having a high safety profile [38].
On the other hand, the results of clinical trials with chitosan dressings showed 
high effectiveness and durability of the anti-haemorrhagic effect. These studies also 
confirmed the safety of the dressing [96]. The antibacterial test confirmed that the 
dressing is bactericidal. Thus, there are currently many different hemostatic dress-
ings based on chitosan on the market.
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